Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Brain Neoplasms 274Glioblastoma 251Glioma 190Neuroblastoma 84Neoplasms 59Central Nervous System Neoplasms 55Astrocytoma 54Medulloblastoma 46Breast Neoplasms 43Melanoma 39Sarcoma 38Neurofibromatosis 1 37Carcinoma, Non-Small-Cell Lung 37Lung Neoplasms 36Meningioma 35Ependymoma 35Osteosarcoma 29Rhabdomyosarcoma 28Diffuse Intrinsic Pontine Glioma 28Recurrence 27Sarcoma, Ewing 26Neoplasm Metastasis 26Rhabdoid Tumor 25Oligodendroglioma 23Wilms Tumor 21Gliosarcoma 21Pancreatic Neoplasms 20Pheochromocytoma 19Hepatoblastoma 19Thyroid Neoplasms 18

Interventions

fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gaucher Disease × CNS × 90 days × Clear all
NCT03721068 2026-03-27

Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma

UNC Lineberger Comprehensive Cancer Center

Phase 1 Recruiting
18 enrolled
CNSSarcoma

Gaucher Disease, Neuroblastoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡